Cargando…

Enhanced activity of NLRP3 inflammasome in peripheral blood cells of patients with active rheumatoid arthritis

INTRODUCTION: Interleukin-1β (IL-1β) is a major inflammatory cytokine, produced predominantly by innate immune cells through NLRP3-inflammasome activation. Both intrinsic and extrinsic danger signals may activate NLRP3. Genetic variations in NLRP3-inflammasome components have been reported to influe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choulaki, Christianna, Papadaki, Garyfallia, Repa, Argyro, Kampouraki, Eleni, Kambas, Konstantinos, Ritis, Konstantinos, Bertsias, George, Boumpas, Dimitrios T., Sidiropoulos, Prodromos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575443/ https://www.ncbi.nlm.nih.gov/pubmed/26385789 http://dx.doi.org/10.1186/s13075-015-0775-2

Ejemplares similares

Progressive Multifocal Leukoencephalopathy in Systemic Lupus Erythematosus: A Consequence of Patient-Intrinsic or -Extrinsic Factors?
por: Emmanouilidou, Evgenia, et al.
Publicado: (2023)

Rheumatoid arthritis patients initiating rituximab with low number of previous bDMARDs failures may effectively reduce rituximab dose and experience fewer serious adverse events than patients on full dose: a 5-year cohort study
por: Bertsias, Antonios, et al.
Publicado: (2022)

Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response
por: Nakou, Magda, et al.
Publicado: (2009)

Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus
por: Adamichou, Christina, et al.
Publicado: (2021)

TLR-9, but not TLR-2, TLR-3 and TLR-4, is upregulated on peripheral blood mononuclear cells of patients with active systemic lupus erythematosus
por: Papadimitraki, ED, et al.
Publicado: (2005)

Rheumatoid arthritis patients on persistent moderate disease activity on biologics have adverse 5-year outcome compared to persistent low-remission status and represent a heterogeneous group
por: Genitsaridi, Irini, et al.
Publicado: (2020)

Nailfold Videocapillaroscopy as a Candidate Biomarker for Organ Involvement and Prognosis in Patients with Systemic Sclerosis
por: Repa, Argyro, et al.
Publicado: (2019)

The value of the 2011 ASAS classification criteria in patients with Spondyloarthritis and the prognosis of non-radiographic axial Spondyloarthritis: data from a large cohort of a tertiary referral hospital
por: Kougkas, Nikolaos, et al.
Publicado: (2019)

Persistence of Depression and Anxiety despite Short-Term Disease Activity Improvement in Patients with Systemic Lupus Erythematosus: A Single-Centre, Prospective Study
por: Nikoloudaki, Myrto, et al.
Publicado: (2022)

Development and Implementation of a Pilot Registry for Monitoring the Efficacy and Safety of Novel Therapies in Patients with Systemic Lupus Erythematosus
por: Adamichou, Christina, et al.
Publicado: (2020)

REDD1/autophagy pathway promotes thromboinflammation and fibrosis in human systemic lupus erythematosus (SLE) through NETs decorated with tissue factor (TF) and interleukin-17A (IL-17A)
por: Frangou, Eleni, et al.
Publicado: (2019)

Correction: Nikoloudaki et al. Persistence of Depression and Anxiety despite Short-Term Disease Activity Improvement in Patients with Systemic Lupus Erythematosus: A Single-Centre, Prospective Study. J. Clin. Med. 2022, 11, 4316
por: Nikoloudaki, Myrto, et al.
Publicado: (2022)

Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance
por: Stagakis, Ilias, et al.
Publicado: (2012)

Anxiety and depression severity in neuropsychiatric SLE are associated with perfusion and functional connectivity changes of the frontolimbic neural circuit: a resting-state f(unctional) MRI study
por: Antypa, Despina, et al.
Publicado: (2021)

Clinical response trajectories and drug persistence in systemic lupus erythematosus patients on belimumab treatment: A real-life, multicentre observational study
por: Nikoloudaki, Myrto, et al.
Publicado: (2023)

Rheumatoid Arthritis-associated Interstitial Lung Disease in Greece: A Multicentre Epidemiological and Clinical Study
por: Karageorgas, Theofanis, et al.
Publicado: (2018)

Twenty Years of Targeted Treatment in Rheumatoid Arthritis in the Greek Databases: Achievements and Unmet Needs
por: Sidiropoulos, Prodromos, et al.
Publicado: (2019)

Altered hippocampal connectivity dynamics predicts memory performance in neuropsychiatric lupus: a resting-state fMRI study using cross-recurrence quantification analysis
por: Pentari, Anastasia, et al.
Publicado: (2023)

Neutrophil Extracellular Trap Formation Is Associated with IL-1β and Autophagy-Related Signaling in Gout
por: Mitroulis, Ioannis, et al.
Publicado: (2011)

The emerging role of neutrophils in thrombosis—the journey of TF through NETs
por: Kambas, Konstantinos, et al.
Publicado: (2012)

Adult Onset Still's Disease: A Case Report with a Rare Clinical Manifestation and Pathophysiological Correlations
por: Antoniou, Katerina M., et al.
Publicado: (2013)

Comparative analysis of the sensitivity and specificity of the classification criteria and correlation with prognosis of disease in patients with Systemic Lupus Erythematosus
por: Adamichou, Christina, et al.
Publicado: (2018)

IFNα Impairs Autophagic Degradation of mtDNA Promoting Autoreactivity of SLE Monocytes in a STING-Dependent Fashion
por: Gkirtzimanaki, Katerina, et al.
Publicado: (2018)

Combined genetic and transcriptome analysis of patients with SLE: distinct, targetable signatures for susceptibility and severity
por: Panousis, Nikolaos I, et al.
Publicado: (2019)

Updated Greek Rheumatology Society Guidelines for the Management of Rheumatoid Arthritis
por: Vassilopoulos, Dimitrios, et al.
Publicado: (2020)

Health outcomes and unmet needs in patients with long-standing rheumatoid arthritis attending tertiary care in Greece: a cohort study
por: Boumpas, Dimitrios T., et al.
Publicado: (2019)

Targeting NLRP3 Inflammasome Activation in Severe Asthma
por: Theofani, Efthymia, et al.
Publicado: (2019)

Metabolic syndrome in rheumatic diseases: epidemiology, pathophysiology, and clinical implications
por: Sidiropoulos, Prodromos I, et al.
Publicado: (2008)

Deciphering the Molecular Mechanism of Flares in Patients with Systemic Lupus Erythematosus through Single-Cell Transcriptome Analysis of the Peripheral Blood
por: Papanikolaou, Sofia, et al.
Publicado: (2022)

Mast cells co-expressing CD68 and inorganic polyphosphate are linked with colorectal cancer
por: Arelaki, Stella, et al.
Publicado: (2018)

Patterns and factors associated with pneumococcal vaccination in a prospective cohort of 1,697 patients with rheumatoid arthritis
por: Thomas, Konstantinos, et al.
Publicado: (2023)

NETs decorated with bioactive IL-33 infiltrate inflamed tissues and induce IFN-α production in patients with SLE
por: Georgakis, Spiros, et al.
Publicado: (2021)

NLRP3 Inflammasome Activation in Peripheral Arterial Disease
por: Bartoli‐Leonard, Francesca, et al.
Publicado: (2023)

Role of NLRP3 Inflammasome in Rheumatoid Arthritis
por: Yin, Hui, et al.
Publicado: (2022)

Calcium-sensing receptor-mediated NLRP3 inflammasome activation in rheumatoid arthritis and autoinflammation
por: Werner, Lina Emilia, et al.
Publicado: (2023)

Corrigendum: Role of NLRP3 inflammasome in rheumatoid arthritis
por: Yin, Hui, et al.
Publicado: (2023)

NLRP3 inflammasome activation is involved in manganese-induced immunotoxicity: Mn activates macrophage NLRP3 inflammasome
por: Ji, Jing, et al.
Publicado: (2021)

The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease
por: Saresella, Marina, et al.
Publicado: (2016)

Real-Life Outcome of Lupus Nephritis with Current Therapies: Study Protocol of a Multicentre Observational Study
por: Pappa, Maria, et al.
Publicado: (2022)

Expression of programmed death (PD)-1 and PD-1 ligands (PD-L1, PD-L2) in peripheral blood mononuclear cells of patients with systemic lupus erythematosus
por: Bertsias, G, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_t1192b0thi6k2kkfmbd5i44ss9